20.41

0.68% -0.14

Core Laboratories Inc (CLB)

Overview News Price History Option Chain Discussions Forecast Stock Split Dividend History

Core Laboratories Inc stock is traded at $20.41, with a volume of 187.86K. It is down -0.68% in the last 24 hours and up +5.04% over the past month. Core Laboratories is the premier provider of reservoir description and production enhancement services for oil and gas exploration and production. It provides data and analytics to aid well operators in determining optimal methods for recovering, processing, and refining hydrocarbons from a well. It also manufactures the associated lab equipment for its services.

Previous Close:

$20.55

Open:

$20.79

24h Volume:

187.86K

Relative Volume:

0.62

Market Cap:

$964.83M

Revenue:

$502.79M

Net Income/Loss:

$23.71M

P/E Ratio:

40.82

EPS:

0.5

Net Cash Flow:

$6.35M

1W Performance:

+0.49%

1M Performance:

+5.04%

6M Performance:

+13.90%

1Y Performance:

+10.26%

1-Day Range:

$20.33

$21.00

1-Week Range:

$20.20

$21.77

52-Week Range:

$13.82

$25.13

Core Laboratories Inc Stock (CLB) Company Profile

Name

Core Laboratories Inc

Sector

Energy (247)

Industry

Oil & Gas Equipment & Services (49)

Phone

713-328-2673

Address

6316 WINDFERN ROAD, HOUSTON

Employee

3,600

Twitter

@corelabcompany

Next Earnings Date

2024-10-23

Latest SEC Filings

CLB's Discussions on Twitter

Compare CLB with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
CLB Core Laboratories Inc	20.41	964.83M	502.79M	23.71M	6.35M	0.50
SLB Schlumberger Ltd	43.66	62.49B	36.00B	4.48B	5.15B	2.89
BKR Baker Hughes Company	43.61	43.07B	27.30B	2.24B	1.79B	1.66
HAL Halliburton Co	31.88	28.07B	23.07B	2.55B	2.40B	2.91
TS Tenaris S A Adr	38.09	21.56B	13.09B	2.65B	2.52B	6.10
FTI Technipfmc Plc	31.01	13.20B	8.79B	671.20M	856.30M	-0.0791

Core Laboratories Inc Stock (CLB) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jun-30-23	Downgrade	Citigroup	Neutral → Sell
Apr-18-23	Downgrade	BofA Securities	Neutral → Underperform
Jan-09-23	Upgrade	BofA Securities	Underperform → Neutral
Oct-07-22	Upgrade	Citigroup	Sell → Neutral
Sep-26-22	Downgrade	Morgan Stanley	Equal-Weight → Underweight
Apr-18-22	Downgrade	Piper Sandler	Neutral → Underweight
Oct-18-21	Downgrade	BofA Securities	Neutral → Underperform
Jul-09-21	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Jun-14-21	Downgrade	Citigroup	Neutral → Sell
Dec-18-20	Downgrade	JP Morgan	Neutral → Underweight
Nov-11-20	Reiterated	Cowen	Market Perform
Oct-13-20	Upgrade	BofA Securities	Underperform → Neutral
Sep-29-20	Upgrade	ABN Amro	Sell → Hold
Jul-16-20	Downgrade	Scotiabank	Sector Outperform → Sector Perform
Apr-13-20	Upgrade	Scotiabank	Sector Perform → Sector Outperform
Mar-09-20	Downgrade	BofA/Merrill	Buy → Underperform
Mar-09-20	Downgrade	Evercore ISI	Outperform → In-line
Jan-31-20	Reiterated	Cowen	Market Perform
Jan-30-20	Resumed	Johnson Rice	Buy
Jan-14-20	Initiated	Bernstein	Mkt Perform
Jan-02-20	Downgrade	Stifel	Buy → Hold
Dec-31-19	Reiterated	Cowen	Market Perform
Jul-10-19	Upgrade	BofA/Merrill	Neutral → Buy
Feb-25-19	Upgrade	Tudor Pickering	Hold → Buy
Dec-19-18	Downgrade	Credit Suisse	Outperform → Neutral
Dec-11-18	Downgrade	JP Morgan	Overweight → Neutral
Nov-16-18	Upgrade	Guggenheim	Neutral → Buy
Nov-01-18	Upgrade	ABN Amro	Sell → Buy
Oct-29-18	Reiterated	Cowen	Market Perform

View All

Core Laboratories Inc Stock (CLB) Latest News

Nov 27, 2024

Core Laboratories (FRA:HJ1) Earnings Yield % : 2.56% (As of Nov. 27, 2024) - GuruFocus.com

Nov 27, 2024

Core Laboratories (FRA:HJ1) Future 3-5Y EPS without NRI Gro - GuruFocus.com

Nov 27, 2024

Core Laboratories (FRA:HJ1) Cash Flow from Operations : €50.6 Mil (TTM As of Sep. 2024) - GuruFocus.com

Nov 27, 2024

Core Laboratories (FRA:HJ1) Free Cash Flow per Share : €0.85 (TTM As of Sep. 2024) - GuruFocus.com

Nov 27, 2024

Nov 26, 2024

Core Laboratories (FRA:HJ1) EPS without NRI : €0.65 (TTM As of Sep. 2024) - GuruFocus.com

Nov 26, 2024

Core Laboratories (FRA:HJ1) EBITDA per Share : €1.42 (TTM As of Sep. 2024) - GuruFocus.com

Nov 26, 2024

Core Laboratories (FRA:HJ1) Operating Income : €48.9 Mil (TTM As of Sep. 2024) - GuruFocus.com

Nov 26, 2024

Core Laboratories (FRA:HJ1) Cyclically Adjusted PB Ratio : 6.41 (As of Nov. 26, 2024) - GuruFocus.com

Nov 26, 2024

Core Laboratories (FRA:HJ1) Total Inventories : €59.0 Mil (As of Sep. 2024) - GuruFocus.com

Nov 26, 2024

Eagle Asset Management Inc. Makes New $3.53 Million Investment in Core Laboratories Inc. (NYSE:CLB) - MarketBeat

Nov 26, 2024

Nov 24, 2024

Oppenheimer & Co. Inc. Reduces Stock Position in Core Laboratories Inc. (NYSE:CLB) - Defense World

Nov 24, 2024

Nov 22, 2024

Why Is Core Laboratories (CLB) Up 11.5% Since Last Earnings Report? - Yahoo Finance

Nov 22, 2024

Core Laboratories (STU:HJ1) Profitability Rank : 7 (As of Sep. 2024) - GuruFocus.com

Nov 22, 2024

Principal Financial Group Inc. Has $4.12 Million Position in Core Laboratories Inc. (NYSE:CLB) - Defense World

Nov 22, 2024

Nov 21, 2024